Imported dengue fever: a 16-years retrospective analysis in Milan (Italy) and a brief review of the European literature.


Journal

Le infezioni in medicina
ISSN: 2532-8689
Titre abrégé: Infez Med
Pays: Italy
ID NLM: 9613961

Informations de publication

Date de publication:
01 Jun 2020
Historique:
entrez: 4 6 2020
pubmed: 4 6 2020
medline: 2 6 2021
Statut: ppublish

Résumé

Dengue Fever (DF), transmitted by Aedes mosquitoes, is the most common arthropod-borne infection, it is almost ubiquitous in tropical and subtropical areas with an estimate of 360 million infections per year. A competent vector (A. albopictus) is present in most of Southern Europe and is endemic in Italy. We conducted a 16-year retrospective study of probable/confirmed dengue fever observed at the Department of Infectious Diseases of Luigi Sacco Hospital in Milan, Italy. Overall 122 patients were included in the study, 106 with probable and 16 with proven diagnosis of dengue fever. Most patients (91%) were Italian, with a median age of 35 years (IQR 29-46 years) and similar gender distribution, travelling for tourism (80%). Asia (mainly South East Asia and Indian Subcontinent) was the most frequent travel destination (55%), followed by Central America and the Caribbeans (22%). August-September was the peak season of presentation (42.6%). The majority of our diagnoses were based on serology alone. The most common signs and symptoms were fever (99,2%), maculopapular rash (50,8%), headache (50,8%), arthralgias (50,8%) and myalgias (46,7%). Leukopenia (77%), thrombocytopenia (81%) and altered LDH, AST and ALT (respectively 60,6%, 54,1% and 45,9%) were the most common laboratory test's abnormalities. No cases of severe DF were recorded. Our epidemiological and clinical findings are largely in accordance with most recent studies about imported DF in Europe. Although very similar in presentation to other arthropod-borne illnesses, some clinical features may help in differentiating DF from other causes of fever in the returning traveler.

Identifiants

pubmed: 32487790

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

243-252

Auteurs

Gabriele Pagani (G)

Dipartimento di Scienze Biomediche e Cliniche "L. Sacco", Universitá degli Studi di Milano, Milano; III Divisione di Malattie Infettive, ASST Fatebenefratelli Sacco, Universitá degli Studi di Milano, Milano.

Nadia Zanchetta (N)

Microbiologia, Virologia e Diagnostica Bioemergenze, ASST Fatebenefratelli Sacco, Milano.

Laura Galimberti (L)

III Divisione di Malattie Infettive, ASST Fatebenefratelli Sacco, Universitá degli Studi di Milano, Milano.

Letizia Oreni (L)

Dipartimento di Scienze Biomediche e Cliniche "L. Sacco", Universitá degli Studi di Milano, Milano.

Simone Passerini (S)

I Divisione di Malattie Infettive, ASST Fatebenefratelli Sacco, Milano.

Andrea Giacomelli (A)

Dipartimento di Scienze Biomediche e Cliniche "L. Sacco", Universitá degli Studi di Milano, Milano.

Laura Cordier (L)

I Divisione di Malattie Infettive, ASST Fatebenefratelli Sacco, Milano.

Maria Rita Gismondo (MR)

Dipartimento di Scienze Biomediche e Cliniche "L. Sacco", Universitá degli Studi di Milano, Milano; Microbiologia, Virologia e Diagnostica Bioemergenze, ASST Fatebenefratelli Sacco, Milano.

Giuliano Rizzardini (G)

I Divisione di Malattie Infettive, ASST Fatebenefratelli Sacco, Milano.

Massimo Galli (M)

Dipartimento di Scienze Biomediche e Cliniche "L. Sacco", Universitá degli Studi di Milano, Milano; III Divisione di Malattie Infettive, ASST Fatebenefratelli Sacco, Universitá degli Studi di Milano, Milano.

Spinello Antinori (S)

Dipartimento di Scienze Biomediche e Cliniche "L. Sacco", Universitá degli Studi di Milano, Milano; III Divisione di Malattie Infettive, ASST Fatebenefratelli Sacco, Universitá degli Studi di Milano, Milano.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH